TALK TO A DOC

Breakouts vs. biology expert = no contest

If you get acne breakouts—even mild ones—you should talk to a doctor. The sooner, the better. After all, the sooner you start a medical treatment, the sooner you can start to see results.

You can talk to any doctor, including your pediatrician, family physician or dermatologist, to figure out the best way to start clearing up your skin.

FIND A DOCTOR

To get the most out of your doctor visit,
you should be ready to talk about your breakouts. Here are a few questions the doctor may ask to better understand your situation, plus a few questions you can ask your doctor as well.

Your doctor may ask:

When did your breakouts start?Have you noticed anything that triggers your breakouts?How do breakouts affect your daily life?What treatment have you tried?What treatment are you using now?

You can ask your doctor:

What are my treatment options?How should I take care of my skin?When should I expect to notice improvement?What should I do if my breakouts get worse?Is Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% right for me?

Print doctor discussion guide

View Important Safety Information

You Could Pay No More Than $35*

You could pay no more than $35* and download the Blame Biology kit

Learn more

Track your progress

Get the mobile app

Help your teen take action

Make a plan

Get the doctor discussion guide

Download the PDF

Important Safety Information
Epiduo® Gel is indicated for the topical treatment of acne vulgaris in patients 12 years and older. Apply to affected skin once daily, avoiding the eyes, lips and mucous membranes. The most common adverse events associated with use of Epiduo® Gel are redness, scaling, dryness, stinging and burning. In addition, you may also experience contact dermatitis and/or skin irritation. These side effects typically resolve during the first four weeks of treatment, but speak to your doctor if they persist. You should avoid excessive exposure to sunlight and sunlamps while using Epiduo® Gel, and use of sunscreen products and protective clothing is recommended. Do not use irritating topical products that contain resorcinol, salicylic acid or sulfur when using Epiduo® Gel. Epiduo® Gel has not been tested in pregnant or nursing women, or with the elderly. Pregnancy Category C. Please see Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

* Insured patients could pay no more than $35 for their Epiduo® Gel prescription (for one tube or pump, after primary insurance and the Epiduo Gel Instant Advantage Card). Restrictions may apply.

©2012 Galderma Laboratories, L.P. United States, All Rights Reserved. All trademarks are the property of their respective owners. This site intended for U.S. audiences only. Information in this website is not intended as medical advice. Talk to your doctor about medical concerns.

Important Safety Information

Close

Epiduo® Gel is indicated for the topical treatment of acne vulgaris in patients 12 years and older. Apply to affected skin once daily, avoiding the eyes, lips and mucous membranes. The most common adverse events associated with use of Epiduo® Gel are redness, scaling, dryness, stinging and burning. In addition, you may also experience contact dermatitis and/or skin irritation. These side effects typically resolve during the first four weeks of treatment, but speak to your doctor if they persist. You should avoid excessive exposure to sunlight and sunlamps while using Epiduo® Gel, and use of sunscreen products and protective clothing is recommended. Do not use irritating topical products that contain resorcinol, salicylic acid or sulfur when using Epiduo® Gel. Epiduo® Gel has not been tested in pregnant or nursing women, or with the elderly. Pregnancy Category C. Please see Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

TWITTER FACEBOOK GOOGLE BUZZ EMAIL
Close

SHARE THE NEWS

All fields are required.

Your Email Address:

Your Name:

Recipient's Email Address:

Send me a copy of this email

View our Privacy Policy